QMCO vs. ABBV

Last updated Apr 2, 2026

Compare and contrast key facts about Quantum Corporation (QMCO) and AbbVie Inc. (ABBV).

Performance

QMCO vs. ABBV - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Quantum Corporation (QMCO) and AbbVie Inc. (ABBV). The values are adjusted to include any dividend payments, if applicable.

QMCO vs. ABBV - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018	2017
QMCO Quantum Corporation	-22.02%	-88.04%	672.49%	-67.98%	-80.25%	-9.80%	-17.52%	271.00%	-64.48%	-15.42%
ABBV AbbVie Inc.	-5.16%	33.08%	18.86%	-0.23%	24.01%	32.43%	27.72%	1.47%	-0.96%	60.07%

Fundamentals

Market Cap QMCO : $68.86M ABBV : $381.37B
EPS QMCO : -$8.86 ABBV : $2.38
PS Ratio QMCO : 0.22 ABBV : 6.23
Total Revenue (TTM) QMCO : $261.28M ABBV : $61.16B
Gross Profit (TTM) QMCO : $97.87M ABBV : $44.85B
EBITDA (TTM) QMCO : -$51.03M ABBV : $28.29B

Returns By Period

In the year-to-date period, QMCO achieves a -22.02% return, which is significantly lower than ABBV's -5.16% return. Over the past 10 years, QMCO has underperformed ABBV with an annualized return of -25.56%, while ABBV has yielded a comparatively higher 18.93% annualized return.

QMCO

• 1D: 5.89%
• 1M: -5.09%
• YTD: -22.02%
• 6M: -53.81%
• 1Y: -64.25%
• 3Y*: -39.75%
• 5Y*: -50.72%
• 10Y*: -25.56%

ABBV

• 1D: -1.15%
• 1M: -8.23%
• YTD: -5.16%
• 6M: -10.68%
• 1Y: 7.72%
• 3Y*: 14.56%
• 5Y*: 19.12%
• 10Y*: 18.93%

*Multi-year figures are annualized to reflect compound growth (CAGR)

Return for Risk

QMCO vs. ABBV — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

QMCO

QMCO Risk / Return Rank: 11
QMCO Sharpe Ratio Rank: 13
QMCO Sortino Ratio Rank: 14
QMCO Omega Ratio Rank: 16
QMCO Calmar Ratio Rank: 5
QMCO Martin Ratio Rank: 8

ABBV

ABBV Risk / Return Rank: 47
ABBV Sharpe Ratio Rank: 51
ABBV Sortino Ratio Rank: 43
ABBV Omega Ratio Rank: 43
ABBV Calmar Ratio Rank: 50
ABBV Martin Ratio Rank: 50

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

QMCO vs. ABBV - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Quantum Corporation (QMCO) and AbbVie Inc. (ABBV). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	QMCO	ABBV	Difference
Sharpe ratio Return per unit of total volatility	-0.63	0.29	-0.92
Sortino ratio Return per unit of downside risk	-0.81	0.56	-1.37
Omega ratio Gain probability vs. loss probability	0.91	1.08	-0.16
Calmar ratio Return relative to maximum drawdown	-0.94	0.36	-1.30
Martin ratio Return relative to average drawdown	-1.55	0.80	-2.35
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

QMCO vs. ABBV - Sharpe Ratio Comparison

The current QMCO Sharpe Ratio is -0.63, which is lower than the ABBV Sharpe Ratio of 0.29. The chart below compares the historical Sharpe Ratios of QMCO and ABBV, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

Sharpe Ratios by Period

	QMCO	ABBV	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	-0.63	0.29	-0.92
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	-0.32	0.85	-1.17
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	-0.21	0.74	-0.94
Sharpe Ratio (All Time) Calculated using the full available price history	-0.21	0.74	-0.95

Correlation

The correlation between QMCO and ABBV is 0.11, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.

Dividends

QMCO vs. ABBV - Dividend Comparison

QMCO has not paid dividends to shareholders, while ABBV's dividend yield for the trailing twelve months is around 3.09%.

	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
QMCO Quantum Corporation	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
ABBV AbbVie Inc.	3.09%	2.87%	3.49%	3.82%	3.49%	3.84%	4.41%	4.83%	3.89%	2.65%	3.64%	3.41%

Drawdowns

QMCO vs. ABBV - Drawdown Comparison

The maximum QMCO drawdown since its inception was -99.93%, which is greater than ABBV's maximum drawdown of -45.09%. Use the drawdown chart below to compare losses from any high point for QMCO and ABBV.

Drawdown Indicators

	QMCO	ABBV	Difference
Max Drawdown Largest peak-to-trough decline	-99.93%	-45.09%	-54.84%
Max Drawdown (1Y) Largest decline over 1 year	-69.17%	-16.31%	-52.86%
Max Drawdown (5Y) Largest decline over 5 years	-98.65%	-21.92%	-76.73%
Max Drawdown (10Y) Largest decline over 10 years	-98.67%	-45.09%	-53.58%
Current Drawdown Current decline from peak	-99.85%	-10.68%	-89.17%
Average Drawdown Average peak-to-trough decline	-88.01%	-10.70%	-77.31%
Ulcer Index Depth and duration of drawdowns from previous peaks	41.84%	7.58%	+34.26%

Volatility

QMCO vs. ABBV - Volatility Comparison

Quantum Corporation (QMCO) has a higher volatility of 27.28% compared to AbbVie Inc. (ABBV) at 7.61%. This indicates that QMCO's price experiences larger fluctuations and is considered to be riskier than ABBV based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	QMCO	ABBV	Difference
Volatility (1M) Calculated over the trailing 1-month period	27.28%	7.61%	+19.67%
Volatility (6M) Calculated over the trailing 6-month period	64.31%	18.69%	+45.62%
Volatility (1Y) Calculated over the trailing 1-year period	101.71%	27.07%	+74.64%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	157.72%	22.62%	+135.10%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	124.19%	25.70%	+98.49%

Financials

QMCO vs. ABBV - Profitability Comparison

The chart below illustrates the profitability comparison between Quantum Corporation and AbbVie Inc. over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

QMCO - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Apr 2026, Quantum Corporation reported a gross profit of 28.93M and revenue of 74.59M. Therefore, the gross margin over that period was 38.8%.

ABBV - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Apr 2026, AbbVie Inc. reported a gross profit of 13.96B and revenue of 16.62B. Therefore, the gross margin over that period was 84.0%.

QMCO - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Apr 2026, Quantum Corporation reported an operating income of -1.19M and revenue of 74.59M, resulting in an operating margin of -1.6%.

ABBV - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Apr 2026, AbbVie Inc. reported an operating income of 5.81B and revenue of 16.62B, resulting in an operating margin of 35.0%.

QMCO - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Apr 2026, Quantum Corporation reported a net income of -27.84M and revenue of 74.59M, resulting in a net margin of -37.3%.

ABBV - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Apr 2026, AbbVie Inc. reported a net income of 1.82B and revenue of 16.62B, resulting in a net margin of 10.9%.